Mechanical thrombectomy was associated with better survival outcomes across patient risk categories and time-to-treatment.

Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

For people with stroke, social factors such as race, neighborhood and insurance, may be linked to whether they receive ...

There are clinical benefits up to 1 year following endovascular thrombectomy for treatment of acute basilar artery occlusion.

Surmodics, Inc. announced it has received FDA 510(k) clearance for its Pounce XL thrombectomy system. The company expects to ...

Professor Powis, alongside the National Clinical Director for Stroke David Hargroves and regional/national colleagues, spent ...

New research shows young adults face large vessel occlusion strokes, once seen mostly in older adults, due to rising stroke ...

A new Harvey L. Neiman Health Policy Institute study found that neurointerventionalists, who often deliver lifesaving and ...

Tenecteplase is a third-generation thrombolytic agent that has a favourable pharmacological profile, compared with alteplase. Tenecteplase has a longer half-life, which allows administration in a ...

Surmodics, Inc. SRDX received the FDA’s 510(k) clearance for its Pounce XL Thrombectomy System yesterday. Following the ...

In recognition of World Thrombosis Day, Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission ...